Amarin's Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats

Vascepa, a fish-oil-derived heart drug, reduced the risk of dying from a heart attack or stroke in a major clinical trial, potentially providing a big benefit for patients and a boost to its maker, Amarin Pharmaceuticals of Bedminster, N.J., which makes no other products.